The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Evaluation of Oncotype DX testing and subsequent patterns of care in patients (pts) with early-stage breast cancer (ESBC).
Meghan Fitzgerald
Employment or Leadership Position - Cardinal Health
Stock Ownership - Cardinal Health
Robert Hassell
Employment or Leadership Position - Cardinal Health
Sally Haislip
No relevant relationships to disclose
James W. Gilmore
No relevant relationships to disclose
Steve Richardson
Employment or Leadership Position - Genomic Health
Joseph Cooper
Employment or Leadership Position - Cardinal Health Specialty Solutions
Stephen Szabo
Employment or Leadership Position - Georgia Cancer Specialist
Consultant or Advisory Role - Amgen
Bruce A. Feinberg
Employment or Leadership Position - Cardinal Health
Stock Ownership - Cardinal Health